CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories

Original ResearchVolume 73, Issue 18, 14 May 2019, Pages 2267-2282

JOURNAL:J Am Coll Cardiol. Article Link

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure

CK Nagaraju, EL Robinson, KR Sipido et al. Keywords: contractile function extracellular matrix fibroblasts inflammation

FULL TEXT PDF